The Pap smear test is a crucial screening for detecting precancerous and cell changes on the cervix.
Women under 21 don't need screening, while those aged 21-29 should get tested every 3 years if results are normal.
For women aged 30-64, a Pap smear every 3 years or a combined Pap and HPV test every 5 years is advised.
Women aged 65 and above can usually skip screening if they have a history of normal results and have had a hysterectomy for non-cancerous conditions.
Screening every 3 years, instead of annually, is now seen as sufficient.
Getting a Pap smear during menstruation is possible, but it's better to reschedule to avoid influence on results.
It's vital not to skip Pap tests. They are key in preventing cervical cancer
Most sexually active individuals have HPV, often without knowing it. Regular Pap smears are essential for detecting HPV.
Meet our expert
Meet our expert
Rate our article
We'd love to know!
0
0
0
0
How was the experience with article?
We'd love to know!
Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. The Lancet, 393(10167), 169-182.
Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., ... & Schiffman, M. (2020). 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of lower genital tract disease, 24(2), 102.
Melnikow, J., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S., & Soulsby, M. A. (2018). Screening for cervical cancer with high-risk human papillomavirus testing: a systematic evidence review for the US Preventive Services Task Force.
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191-e203.
Petry, K. U. (2014). HPV and cervical cancer. Scandinavian Journal of Clinical and Laboratory Investigation, 74(sup244), 59-62.
Wang, R., Pan, W., Jin, L., Huang, W., Li, Y., Wu, D., ... & Liao, S. (2020). Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer letters, 471, 88-102.
Ruhl JL, Callaghan C, Hurlbut, A, Ries LAG, Adamo P, Dickie L, Schussler N (eds.) Summary Stage 2018: Codes and Coding Instructions, National Cancer Institute, Bethesda, MD, 2018.
How was the experience with article?
We'd love to know!